financetom
Business
financetom
/
Business
/
Trump pardons former US congressman convicted of securities fraud
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump pardons former US congressman convicted of securities fraud
Jun 5, 2026 8:08 PM

WASHINGTON, June 5 (Reuters) - President Donald Trump

has pardoned former U.S. Representative Stephen Buyer, an

Indiana Republican, who was convicted of securities fraud for

engaging in insider trading in 2018 as a T-Mobile US ( TMUS ) consultant

ahead of a $23 billion merger with Sprint.

The proclamation, issued on Thursday and announced by the

White House on Friday, gave no specific rationale for the pardon

other than to assert that Buyer's service as a U.S. Army judge

advocate general and member of Congress "was distinguished and

highly productive."

It also said that Trump, in granting Buyer a "full, complete

and unconditional pardon," was acting on the "advice and

recommendation" of 52 current and former members of the U.S.

Senate and House of Representatives listed in the proclamation.

Buyer served in the House as a Republican from Indiana

between 1993 and 2011 before working as a corporate consultant.

He was found guilty in March of 2023 on four counts of

securities fraud, and was sentenced in September of that year to

22 months in prison.

Prosecutors said at trial that Buyer bought Sprint stock

after learning from a T-Mobile executive that the

telecommunications companies were in merger talks in 2018 and

made illegal trades again the following year.

According to prosecutors, Buyer made more than $100,000 from

the Sprint trades and more than $200,000 from buying stock in

Navigant Consulting Inc. before it was acquired by Guidehouse in

2019.

Buyer, who had served as one of the House managers in the

1999 impeachment trial of then-President Bill Clinton, took the

stand at his own trial and denied trading on inside information.

Prosecutors sought three years in prison for Buyer in court

filings, saying that he had abused his clients' trust and lied

on the stand.

The U.S. Supreme Court refused in May of this year to hear

Buyer's appeal of his conviction.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
South Korea says Nvidia, Hyundai Motor to create $3 billion AI joint venture
South Korea says Nvidia, Hyundai Motor to create $3 billion AI joint venture
Oct 31, 2025
GYEONGJU, South Korea, Oct 31 (Reuters) - U.S. chipmaker Nvidia ( NVDA ) and South Korean automaker Hyundai Motor Group plan to invest $3 billion to create a joint venture on physical artificial intelligence, South Korea's presidential office said at a briefing on Friday. ...
Casella Waste Systems Q3 Adjusted Earnings Decline, Revenue Rises
Casella Waste Systems Q3 Adjusted Earnings Decline, Revenue Rises
Oct 31, 2025
03:38 AM EDT, 10/31/2025 (MT Newswires) -- Casella Waste Systems ( CWST ) reported Q3 adjusted earnings late Thursday of $0.42 per diluted share, down from $0.44 a year earlier. Analysts polled by FactSet expected $0.32. Revenue for the quarter ended Sept. 30 was $485.4 million, up from $411.6 million a year ago. Analysts surveyed by FactSet expected $476.3 million....
Gerdau Q3 Earnings Decline, Net Sales Increase
Gerdau Q3 Earnings Decline, Net Sales Increase
Oct 31, 2025
03:41 AM EDT, 10/31/2025 (MT Newswires) -- Gerdau ( GGB ) reported Q3 earnings Thursday of 0.54 Brazilian real ($0.10) per share, down from 0.64 real a year earlier. Analysts polled by FactSet expected 0.61 real. Net sales for the quarter ended Sept. 30 were 17.98 billion reais, up from 17.38 billion reais a year earlier. Analysts surveyed by FactSet...
Arcutis Biotherapeutics Insider Sold Shares Worth $1,001,032, According to a Recent SEC Filing
Arcutis Biotherapeutics Insider Sold Shares Worth $1,001,032, According to a Recent SEC Filing
Oct 31, 2025
03:39 AM EDT, 10/31/2025 (MT Newswires) -- Todd Watanabe, Director, President and Chief Executive Officer, on October 28, 2025, sold 40,000 shares in Arcutis Biotherapeutics ( ARQT ) for $1,001,032. Following the Form 4 filing with the SEC, Watanabe has control over a total of 1,039,574 common shares of the company, with 806,440 shares held directly and 233,134 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved